85 results on '"Fayad ZA"'
Search Results
2. Associations of plasma C-Reactive Protein and osteopontin levels with the severities of coronary and aortic atherosclerosis
- Author
-
Nakamura Haruo, Nagata Masayoshi, Taniguchi Hiroaki, Kato Ryuichi, Kihara Teruyoshi, Fayad Zahi A, Ohmori Reiko, Momiyama Yukihiko, and Ohsuzu Fumitaka
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Published
- 2009
- Full Text
- View/download PDF
3. MR imaging of human atherosclerosis using immunomicelles molecularly targeted to macrophages
- Author
-
Fuster Valentin, Masey David, Aguinaldo Juan GS, Abbate Antonio, Samber Daniel, Mani Venkatesh, Briley-Saebo Karen C, Amirbekian Smbat, Frias Juan C, Lipinski Michael J, Amirbekian Vardan, Vetrovec George, and Fayad Zahi A
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Published
- 2009
- Full Text
- View/download PDF
4. 1038 Magnetic resonance evaluation of the associations of thoracic and abdominal aortic plaques with the presense and extent of coronary artery stenosis
- Author
-
Nagata Masayoshi, Kihara Teruyoshi, Ohmori Reiko, Tanaka Nobukiyo, Kato Ryuichi, Fayad Zahi A, Taniguchi Hiroaki, Momiyama Yukihiko, Nakamura Haruo, and Ohsuzu Fumitaka
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Published
- 2008
- Full Text
- View/download PDF
5. Variations in atherosclerosis and remodeling patterns in aorta and carotids
- Author
-
Fuster Valentin, Postley John E, Aguiar Silvia, Nemade Ajay, Mani Venkatesh, Hayashi Katsumi, and Fayad Zahi A
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Background Atherosclerosis is a progressive disease that causes vascular remodeling that can be positive or negative. The evolution of arterial wall thickening and changes in lumen size under current "standard of care" in different arterial beds is unclear. The purpose of this study was to examine arterial remodeling and progression/regression of atherosclerosis in aorta and carotid arteries of individuals at risk for atherosclerosis normalized over a 1-year period. Methods In this study, 28 patients underwent at least 2 black-blood in vivo cardiovascular magnetic resonance (CMR) scans of aorta and carotids over a one-year period (Mean 17.8 ± 7.5 months). Clinical risk profiles for atherosclerosis and medications were documented and patients were followed by their referring physicians under current "standard of care" guidelines. Carotid and aortic wall lumen areas were matched across the time-points from cross-sectional images. Results The wall area increased by 8.67%, 10.64%, and 13.24% per year (carotid artery, thoracic aorta and abdominal aorta respectively, p < 0.001). The lumen area of the abdominal aorta increased by 4.97% per year (p = 0.002), but the carotid artery and thoracic aorta lumen areas did not change significantly. The use of statin therapy did not change the rate of increase of wall area of carotid artery, thoracic and abdominal aorta, but decreased the rate of change of lumen area of carotid artery (-3.08 ± 11.34 vs. 0.19 ± 12.91 p < 0.05). Conclusions Results of this study of multiple vascular beds indicated that different vascular locations exhibited varying progression of atherosclerosis and remodeling as monitored by CMR.
- Published
- 2010
- Full Text
- View/download PDF
6. Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events
- Author
-
Bansilal Sameer, Reiber Johan HC, van der Geest Rob, Taniguchi Hiroaki, Weinshelbaum Karen B, El Aidi Hamza, Aguiar Silvia H, Gidding Samuel S, Muntner Paul, Mani Venkatesh, Farkouh Michael, Fuster Valentin, Postley John E, Woodward Mark, and Fayad Zahi A
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Aims Patients with prior major cardiovascular or cerebrovascular events (MACE) are more likely to have future recurrent events independent of traditional cardiovascular disease risk factors. The purpose of this study was to determine if patients with traditional risk factors and prior MACE had increased cardiovascular magnetic resonance (CMR) plaque burden measures compared to patients with risk factors but no prior events. Methods and Results Black blood carotid and thoracic aorta images were obtained from 195 patients using a rapid extended coverage turbo spin echo sequence. CMR measures of plaque burden were obtained by tracing lumen and outer vessel wall contours. Patients with prior MACE had significantly higher MR plaque burden (wall thickness, wall area and normalized wall index) in carotids and thoracic aorta compared to those without prior MACE (Wall thickness carotids: 1.03 ± 0.03 vs. 0.93± 0.03, p = 0.001; SD wall thickness carotids: 0.137 ± 0.0008 vs. 0.102 ± 0.0004, p < 0.001; wall thickness aorta: 1.63 ± 0.10 vs. 1.50 ± 0.04, p = 0.009; SD wall thickness aorta: 0.186 ± 0.035 vs. 0.139 ± 0.012, p = 0.009 respectively). Plaque burden (wall thickness) and plaque eccentricity (standard deviation of wall thickness) of carotid arteries were associated with prior MACE after adjustment for age, sex, and traditional risk factors. Area under ROC curve (AUC) for discriminating prior MACE improved by adding plaque eccentricity to models incorporating age, sex, and traditional CVD risk factors as model inputs (AUC = 0.79, p = 0.05). Conclusion A greater plaque burden and plaque eccentricity is prevalent among patients with prior MACE.
- Published
- 2009
- Full Text
- View/download PDF
7. Specific locations of myocardial inflammation and fibrosis are associated with higher risk of events in cardiac sarcoidosis.
- Author
-
Devesa A, Robson PM, Cangut B, Vazirani R, Vergani V, LaRocca G, Romero-Daza AM, Liao S, Azoulay LD, Pyzik R, Fayad RA, Jacobi A, Abgral R, Morgenthau AS, Miller MA, Fayad ZA, and Trivieri MG
- Abstract
Background:
18 F-FDG-PET/MR can identify inflammation and fibrosis, high-risk features in cardiac sarcoidosis., Objective: To evaluate whether the involvement of certain myocardial segments is associated with higher risk compared to others., Methods: 124 patients with suspected clinical sarcoidosis underwent18 F-FDG-PET/MR. Late gadolinium enhancement (LGE) and focal18 F-FDG uptake were evaluated globally and in the 16 myocardial segments. Presence of LGE was defined when the percentage of LGE exceeded 5.7% globally (relative to myocardial volume) and in each myocardial segment. Patients were followed up for 5.5 years. Events were defined as ventricular arrhythmia (VA, including sustained ventricular tachycardia, ventricular fibrillation, and appropriate ICD discharge), heart failure hospitalization, or all-cause death., Results: Mean age was 57.1±8.9 years, and 39.5% were female; 22 patients (17.6%) had an event at follow-up, and 9 (7.2%) presented VA. LGE and18 F-FDG uptake were more frequent in patients with than without events (36.4% vs 7.8%, p=0.001). Presence of LGE or18 F-FDG in the basal anterior segment were independent predictors for events after adjustment by left ventricular ejection fraction and relative enhanced volume (LGE: OR 10.5[1.2-92.4]; p=0.034;18 F-FDG: OR 5.5[1.1-27.5], p=0.038). LGE presence in basal to mid anterior, mid anteroseptal, and basal to mid inferoseptal segments was an independent predictor for VA. Presence of18 F-FDG in basal to mid anterior, mid inferoseptal and mid inferior segments was an independent predictor for VA., Conclusion: Involvement of specific myocardial segments, particularly basal to mid anterior and mid septal segments, is associated with higher rates of events in patients with suspected cardiac sarcoidosis., (Copyright © 2024. Published by Elsevier Inc.)- Published
- 2024
- Full Text
- View/download PDF
8. Trained immunity suppression determines kidney allograft survival.
- Author
-
Jonkman I, Jacobs MME, Negishi Y, Yanginlar C, Martens JHA, Baltissen M, Vermeulen M, van den Hoogen MWF, Baas M, van der Vlag J, Fayad ZA, Teunissen AJP, Madsen JC, Ochando J, Joosten LAB, Netea MG, Mulder WJM, Mhlanga MM, Hilbrands LB, Rother N, and Duivenvoorden R
- Abstract
The innate immune system plays an essential role in regulating the immune responses to kidney transplantation, but the mechanisms through which innate immune cells influence long-term graft survival are unclear. The current study highlights the vital role of trained immunity in kidney allograft survival. Trained immunity describes the epigenetic and metabolic changes that innate immune cells undergo following an initial stimulus, allowing them have a stronger inflammatory response to subsequent stimuli. We stimulated healthy peripheral blood mononuclear cells with pretransplant and posttransplant serum of kidney transplant patients and immunosuppressive drugs in an in vitro trained immunity assay and measured tumor necrosis factor and interleukin 6 cytokine levels in the supernatant as a readout for trained immunity. We show that the serum of kidney transplant recipients collected 1 week after transplantation can suppress trained immunity. Importantly, we found that kidney transplant recipients whose serum most strongly suppressed trained immunity rarely experienced graft loss. This suppressive effect of posttransplant serum is likely mediated by previously unreported effects of immunosuppressive drugs. Our findings provide mechanistic insights into the role of innate immunity in kidney allograft survival, uncovering trained immunity as a potential therapeutic target for improving graft survival., Competing Interests: Declaration of competing interest The authors of this manuscript have conflicts of interest to disclose as described by the American Journal of Transplantation. L. A. B. Joosten is scientific founder of TTxD, LembaTX, and SalvinaTX. M. G. Netea is scientific founder of TTxD and Biotrip. W. J. M. Mulder is scientific founder of TTxD and Biotrip. Other authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
9. Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis.
- Author
-
Trivieri MG, Robson PM, Vergani V, LaRocca G, Romero-Daza AM, Abgral R, Devesa A, Azoulay LD, Karakatsanis NA, Parikh A, Panagiota C, Palmisano A, DePalo L, Chang HL, Rothstein JH, Fayad RA, Miller MA, Fuster V, Narula J, Dweck MR, Morgenthau A, Jacobi A, Padilla M, Kovacic JC, and Fayad ZA
- Subjects
- Humans, Fluorodeoxyglucose F18, Contrast Media, Radiopharmaceuticals, Predictive Value of Tests, Gadolinium, Positron-Emission Tomography methods, Magnetic Resonance Imaging methods, Magnetic Resonance Spectroscopy, Cardiomyopathies diagnostic imaging, Cardiomyopathies therapy, Cardiomyopathies complications, Myocarditis complications, Sarcoidosis diagnostic imaging, Sarcoidosis therapy, Sarcoidosis complications
- Abstract
Background: Imaging with late gadolinium enhancement (LGE) magnetic resonance (MR) and
18 F-fluorodeoxyglucose (18 F-FDG) PET allows complementary assessment of myocardial injury and disease activity and has shown promise for improved characterization of active cardiac sarcoidosis (CS) based on the combined positive imaging outcome, MR(+)PET(+)., Objectives: This study aims to evaluate qualitative and quantitative assessments of hybrid MR/PET imaging in CS and to evaluate its association with cardiac-related outcomes., Methods: A total of 148 patients with suspected CS underwent hybrid MR/PET imaging. Patients were classified based on the presence/absence of LGE (MR+/MR-), presence/absence of18 F-FDG (PET+/PET-), and pattern of18 F-FDG uptake (focal/diffuse) into the following categories: MR(+)PET(+)FOCAL , MR(+)PET(+)DIFFUSE , MR(+)PET(-), MR(-)PET(+)FOCAL , MR(-)PET(+)DIFFUSE , MR(-)PET(-). Further analysis classified MR positivity based on %LGE exceeding 5.7% as MR(+/-)5.7% . Quantitative values of standard uptake value, target-to-background ratio, target-to-normal-myocardium ratio (TNMRmax), and T2 were measured. The primary clinical endpoint was met by the occurrence of cardiac arrest, ventricular tachycardia, or secondary prevention implantable cardioverter-defibrillator (ICD) before the end of the study. The secondary endpoint was met by any of the primary endpoint criteria plus heart failure or heart block. MR/PET imaging results were compared between those meeting or not meeting the clinical endpoints., Results: Patients designated MR(+)5.7% PET(+)FOCAL had increased odds of meeting the primary clinical endpoint compared to those with all other imaging classifications (unadjusted OR: 9.2 [95% CI: 3.0-28.7]; P = 0.0001), which was higher than the odds based on MR or PET alone. TNMRmax achieved an area under the receiver-operating characteristic curve of 0.90 for separating MR(+)PET(+)FOCAL from non-MR(+)PET(+)FOCAL , and 0.77 for separating those reaching the clinical endpoint from those not reaching the clinical endpoint., Conclusions: Hybrid MR/PET image-based classification of CS was statistically associated with clinical outcomes in CS. TNMRmax had modest sensitivity and specificity for quantifying the imaging-based classification MR(+)PET(+)FOCAL and was associated with outcomes. Use of combined MR and PET image-based classification may have use in prognostication and treatment management in CS., Competing Interests: Funding Support and Author Disclosures This work was supported by National Institutes of Health (NIH) grant R01 HL071021 (ZAF), NIH grant KL2 TR001435 (MGT), and AHA grant 20CDA35310099 (MGT). The authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2024. Published by Elsevier Inc.)- Published
- 2024
- Full Text
- View/download PDF
10. 18 F-FDG PET/CT in left ventricular assist device infections: In-depth characterization and clinical implications.
- Author
-
Devesa A, Rashed E, Moss N, Robson PM, Pyzik R, Roldan J, Taimur S, Rana MM, Ashley K, Young A, Patel G, Mahmood K, Mitter SS, Lala A, Barghash M, Fox A, Correa A, Pirlamarla P, Contreras J, Parikh A, Mancini D, Jacobi A, Ghesani N, Gavane SC, Ghesani M, Itagaki S, Anyanwu A, Fayad ZA, and Trivieri MG
- Subjects
- Humans, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography methods, Tomography, X-Ray Computed, Retrospective Studies, Heart-Assist Devices adverse effects, Prosthesis-Related Infections diagnostic imaging, Prosthesis-Related Infections etiology, Bacteremia diagnosis, Bacteremia etiology
- Abstract
Background: Previous retrospective studies suggest a good diagnostic performance of
18 F-fluorodeoxyglucose positron emission tomography (18 F-FDG-PET)/computed tomography (CT) in left ventricular assist device (LVAD) infections. Our aim was to prospectively evaluate the role of PET/CT in the characterization and impact on clinical management of LVAD infections., Methods: A total of 40 patients (aged 58 [53-62] years) with suspected LVAD infection and 5 controls (aged 69 [64-71] years) underwent18 F-FDG-PET/CT. Four LVAD components were evaluated: exit site and subcutaneous driveline (peripheral), pump pocket, and outflow graft. The location with maximal uptake was considered the presumed site of infection. Infection was confirmed by positive culture (exit site or blood) and/or surgical findings., Results: Visual uptake was present in 40 patients (100%) in the infection group vs 4 (80%) control subjects. For each individual component, the presence of uptake was more frequent in the infection than in the control group. The location of maximal uptake was most frequently the pump pocket (48%) in the infection group and the peripheral components (75%) in the control group. Maximum standard uptake values (SUVmax ) were higher in the infection than in the control group: SUVmax (average all components): 6.9 (5.1-8.5) vs 3.8 (3.7-4.3), p = 0.002; SUVmax (location of maximal uptake): 10.6 ± 4.0 vs 5.4 ± 1.9, p = 0.01. Pump pocket infections were more frequent in patients with bacteremia than without bacteremia (79% vs 31%, p = 0.011). Pseudomonas (32%) and methicillin-susceptible Staphylococcus aureus (29%) were the most frequent pathogens and were associated with pump pocket infections, while Staphylococcus epidermis (11%) was associated with peripheral infections. PET/CT affected the clinical management of 83% of patients with infection, resulting in surgical debridement (8%), pump exchange (13%), and upgrade in the transplant listing status (10%), leading to 8% of urgent transplants., Conclusions:18 F-FDG-PET/CT enables the diagnosis and characterization of the extent of LVAD infections, which can significantly affect the clinical management of these patients., (Copyright © 2023 International Society for the Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
11. PTSD increases risk for major adverse cardiovascular events through neural and cardio-inflammatory pathways.
- Author
-
Seligowski AV, Grewal SS, Abohashem S, Zureigat H, Qamar I, Aldosoky W, Gharios C, Hanlon E, Alani O, Bollepalli SC, Armoundas A, Fayad ZA, Shin LM, Osborne MT, and Tawakol A
- Subjects
- Humans, C-Reactive Protein, Heart, Stress Disorders, Post-Traumatic, Cardiovascular System, Cardiovascular Diseases
- Abstract
While posttraumatic stress disorder (PTSD) is known to associate with an elevated risk for major adverse cardiovascular events (MACE), few studies have examined mechanisms underlying this link. Recent studies have demonstrated that neuro-immune mechanisms, (manifested by heightened stress-associated neural activity (SNA), autonomic nervous system activity, and inflammation), link common stress syndromes to MACE. However, it is unknown if neuro-immune mechanisms similarly link PTSD to MACE. The current study aimed to test the hypothesis that upregulated neuro-immune mechanisms increase MACE risk among individuals with PTSD. This study included N = 118,827 participants from a large hospital-based biobank. Demographic, diagnostic, and medical history data collected from the biobank. SNA (n = 1,520), heart rate variability (HRV; [n = 11,463]), and high sensitivity C-reactive protein (hs-CRP; [n = 15,164]) were obtained for a subset of participants. PTSD predicted MACE after adjusting for traditional MACE risk factors (hazard ratio (HR) [95 % confidence interval (CI)] = 1.317 [1.098, 1.580], β = 0.276, p = 0.003). The PTSD-to-MACE association was mediated by SNA (CI = 0.005, 0.133, p < 0.05), HRV (CI = 0.024, 0.056, p < 0.05), and hs-CRP (CI = 0.010, 0.040, p < 0.05). This study provides evidence that neuro-immune pathways may play important roles in the mechanisms linking PTSD to MACE. Future studies are needed to determine if these markers are relevant targets for PTSD treatment and if improvements in SNA, HRV, and hs-CRP associate with reduced MACE risk in this patient population., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
12. Influence of thoracic radiology training on classification of interstitial lung diseases.
- Author
-
Lange M, Boddu P, Singh A, Gross BD, Mei X, Liu Z, Bernheim A, Chung M, Huang M, Masseaux J, Dua S, Platt S, Sivakumar G, DeMarco C, Lee J, Fayad ZA, Yang Y, Padilla M, and Jacobi A
- Subjects
- Humans, Retrospective Studies, Tomography, X-Ray Computed methods, Radiography, Thoracic, Lung pathology, Lung Diseases, Interstitial diagnostic imaging, Lung Diseases, Interstitial pathology, Radiology education
- Abstract
Introduction: Interpretation of high-resolution CT images plays an important role in the diagnosis and management of interstitial lung diseases. However, interreader variation may exist due to varying levels of training and expertise. This study aims to evaluate interreader variation and the role of thoracic radiology training in classifying interstitial lung disease (ILD)., Methods: This is a retrospective study where seven physicians (radiologists, thoracic radiologists, and a pulmonologist) classified the subtypes of ILD of 128 patients from a tertiary referral center, all selected from the Interstitial Lung Disease Registry which consists of patients from November 2014 to January 2021. Each patient was diagnosed with a subtype of interstitial lung disease by a consensus diagnosis from pathology, radiology, and pulmonology. Each reader was provided with only clinical history, only CT images, or both. Reader sensitivity and specificity and interreader agreements using Cohen's κ were calculated., Results: Interreader agreement based only on clinical history, only on radiologic information, or combination of both was most consistent amongst readers with thoracic radiology training, ranging from fair (Cohen's κ: 0.2-0.46), moderate to almost perfect (Cohen's κ: 0.55-0.92), and moderate to almost perfect (Cohen's κ: 0.53-0.91) respectively. Radiologists with any thoracic training showed both increased sensitivity and specificity for NSIP as compared to other radiologists and the pulmonologist when using only clinical history, only CT information, or combination of both (p < 0.05)., Conclusions: Readers with thoracic radiology training showed the least interreader variation and were more sensitive and specific at classifying certain subtypes of ILD., Summary Sentence: Thoracic radiology training may improve sensitivity and specificity in classifying ILD based on HRCT images and clinical history., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
13. Performance of spiral UTE-MRI of the lung in post-COVID patients.
- Author
-
Fauveau V, Jacobi A, Bernheim A, Chung M, Benkert T, Fayad ZA, and Feng L
- Subjects
- Humans, Lung diagnostic imaging, Lung pathology, Magnetic Resonance Imaging methods, Breath Holding, Imaging, Three-Dimensional methods, Post-Acute COVID-19 Syndrome, COVID-19 diagnostic imaging
- Abstract
Patients recovered from COVID-19 may develop long-COVID symptoms in the lung. For this patient population (post-COVID patients), they may benefit from longitudinal, radiation-free lung MRI exams for monitoring lung lesion development and progression. The purpose of this study was to investigate the performance of a spiral ultrashort echo time MRI sequence (Spiral-VIBE-UTE) in a cohort of post-COVID patients in comparison with CT and to compare image quality obtained using different spiral MRI acquisition protocols. Lung MRI was performed in 36 post-COVID patients with different acquisition protocols, including different spiral sampling reordering schemes (line in partition or partition in line) and different breath-hold positions (inspiration or expiration). Three experienced chest radiologists independently scored all the MR images for different pulmonary structures. Lung MR images from spiral acquisition protocol that received the highest image quality scores were also compared against corresponding CT images in 27 patients for evaluating diagnostic image quality and lesion identification. Spiral-VIBE-UTE MRI acquired with the line in partition reordering scheme in an inspiratory breath-holding position achieved the highest image quality scores (score range = 2.17-3.69) compared to others (score range = 1.7-3.29). Compared to corresponding chest CT images, three readers found that 81.5% (22 out of 27), 81.5% (22 out of 27) and 37% (10 out of 27) of the MR images were useful, respectively. Meanwhile, they all agreed that MRI could identify significant lesions in the lungs. The Spiral-VIBE-UTE sequence allows for fast imaging of the lung in a single breath hold. It could be a valuable tool for lung imaging without radiation and could provide great value for managing different lung diseases including assessment of post-COVID lesions., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
14. Exploring Atherosclerosis Imaging With FDG-PET in Motion.
- Author
-
Fayad ZA and Calcagno C
- Subjects
- Humans, Predictive Value of Tests, Positron-Emission Tomography, Atherosclerosis diagnostic imaging
- Abstract
Competing Interests: Funding Support and Author Disclosures Dr Fayad is supported by the National Institutes of Health, National Heart, Lung, and Blood Institute (R01 HL071021, R01 HL128056, HL135878, and P01 HL131478) and the National Institute of Biomedical Imaging and Bioengineering (R01 EB009638). Dr Calcagno has reported that she has no relationships relevant to the contents of this paper to disclose.
- Published
- 2022
- Full Text
- View/download PDF
15. Pulmonary Artery 18 F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis.
- Author
-
Maier A, Liao SL, Lescure T, Robson PM, Hirata N, Sartori S, Narula N, Vergani V, Soultanidis G, Morgenthau A, Kovacic JC, Padilla M, Narula J, Jacobi A, Fayad ZA, and Trivieri MG
- Subjects
- Fluorodeoxyglucose F18, Humans, Magnetic Resonance Spectroscopy, Positron-Emission Tomography, Predictive Value of Tests, Pulmonary Artery, Radiopharmaceuticals, Hypertension, Pulmonary diagnostic imaging, Hypertension, Pulmonary etiology, Sarcoidosis complications, Sarcoidosis diagnostic imaging, Sarcoidosis pathology
- Abstract
Objectives: This study investigated whether pulmonary artery (PA)
18 F-FDG uptake is associated with hypertension, and if it correlates to elevated pulmonary pressures., Background:18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET) combined with computed tomography or cardiac magnetic resonance (CMR) has been used to assess inflammation mostly in large arteries of the systemic circulation. Much less is known about inflammation of the vasculature of the pulmonary system and its relationship to pulmonary hypertension (PH)., Methods: In a single-center cohort of 175 patients with suspected cardiac sarcoidosis, who underwent hybrid thoracic PET/CMR,18 F-FDG uptake in the PA was quantified according to maximum standardized uptake value (SUVmax) and target-to-background ratio (TBR) and compared with available results from right heart catheterization (RHC) or transthoracic echocardiography (TTE)., Results: Thirty-three subjects demonstrated clear18 F-FDG uptake in the PA wall. In the subgroup of patients who underwent RHC (n = 10), the mean PA pressure was significantly higher in the group with PA18 F-FDG uptake compared with the group without uptake (34.4 ± 7.2 mm Hg vs 25.6 ± 9.3 mm Hg; P = 0.003), and 9 (90%) patients with PA18 F-FDG uptake had PH when a mean PA pressure cutoff of 25 mm Hg was used compared with 18 (45%) in the nonuptake group (P < 0.05). In the subgroup that underwent TTE, signs of PH were present in a significantly higher number of patients with PA18 F-FDG uptake (14 [51.9%] vs 37 [29.8%]; P < 0.05). Qualitative assessment of18 F-FDG uptake in the PA wall showed a sensitivity of 33% and specificity of 96% for separating patients with PH based on RHC-derived PA pressures. SUVmax and TBR in the PA wall correlated with PA pressure derived from RHC and/or TTE., Conclusions: We demonstrate that18 F-FDG uptake by PET/CMR in the PA is associated with PH and that its intensity correlates with PA pressure., Competing Interests: Funding Support and Author Disclosures Dr Maier was supported by a Deutsche Forschungsgemeinschaft research grant (MA 7059/1). Drs Robson Fayad were supported by a National Institutes of Health grant. Dr Trivieri was supported by a National Center for Advancing Translational Sciences (NCATS) award (KL2 TR001435). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
16. Coronary artery calcification in COVID-19 patients: an imaging biomarker for adverse clinical outcomes.
- Author
-
Gupta YS, Finkelstein M, Manna S, Toussie D, Bernheim A, Little BP, Concepcion J, Maron SZ, Jacobi A, Chung M, Kukar N, Voutsinas N, Cedillo MA, Fernandes A, Eber C, Fayad ZA, and Hota P
- Subjects
- Adult, Biomarkers, Coronary Angiography, Coronary Vessels diagnostic imaging, Humans, Predictive Value of Tests, Retrospective Studies, Risk Factors, SARS-CoV-2, Young Adult, COVID-19, Coronary Artery Disease diagnostic imaging, Vascular Calcification diagnostic imaging, Vascular Calcification epidemiology
- Abstract
Background: Recent studies have demonstrated a complex interplay between comorbid cardiovascular disease, COVID-19 pathophysiology, and poor clinical outcomes. Coronary artery calcification (CAC) may therefore aid in risk stratification of COVID-19 patients., Methods: Non-contrast chest CT studies on 180 COVID-19 patients ≥ age 21 admitted from March 1, 2020 to April 27, 2020 were retrospectively reviewed by two radiologists to determine CAC scores. Following feature selection, multivariable logistic regression was utilized to evaluate the relationship between CAC scores and patient outcomes., Results: The presence of any identified CAC was associated with intubation (AOR: 3.6, CI: 1.4-9.6) and mortality (AOR: 3.2, CI: 1.4-7.9). Severe CAC was independently associated with intubation (AOR: 4.0, CI: 1.3-13) and mortality (AOR: 5.1, CI: 1.9-15). A greater CAC score (UOR: 1.2, CI: 1.02-1.3) and number of vessels with calcium (UOR: 1.3, CI: 1.02-1.6) was associated with mortality. Visualized coronary stent or coronary artery bypass graft surgery (CABG) had no statistically significant association with intubation (AOR: 1.9, CI: 0.4-7.7) or death (AOR: 3.4, CI: 1.0-12)., Conclusion: COVID-19 patients with any CAC were more likely to require intubation and die than those without CAC. Increasing CAC and number of affected arteries was associated with mortality. Severe CAC was associated with higher intubation risk. Prior CABG or stenting had no association with elevated intubation or death., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
17. Portable Chest Radiography as an Exclusionary Test for Adverse Clinical Outcomes During the COVID-19 Pandemic.
- Author
-
Pagano A, Finkelstein M, Overbey J, Steinberger S, Ellison T, Manna S, Toussie D, Cedillo MA, Jacobi A, Gupta YS, Bernheim A, Chung M, Eber C, Fayad ZA, and Concepcion J
- Subjects
- Female, Hospital Mortality, Humans, Male, Middle Aged, New York City epidemiology, Predictive Value of Tests, Respiration, Artificial methods, Retrospective Studies, SARS-CoV-2, COVID-19 diagnosis, COVID-19 mortality, COVID-19 therapy, Hospitalization statistics & numerical data, Lung diagnostic imaging, Radiography, Thoracic methods, Radiography, Thoracic standards, Radiography, Thoracic statistics & numerical data, Respiration Disorders diagnosis, Respiration Disorders etiology, Respiration, Artificial statistics & numerical data
- Abstract
Background: Chest radiography (CXR) often is performed in the acute setting to help understand the extent of respiratory disease in patients with COVID-19, but a clearly defined role for negative chest radiograph results in assessing patients has not been described., Research Question: Is portable CXR an effective exclusionary test for future adverse clinical outcomes in patients suspected of having COVID-19?, Study Design and Methods: Charts of consecutive patients suspected of having COVID-19 at five EDs in New York City between March 19, 2020, and April 23, 2020, were reviewed. Patients were categorized based on absence of findings on initial CXR. The primary outcomes were hospital admission, mechanical ventilation, ARDS, and mortality., Results: Three thousand two hundred forty-five adult patients, 474 (14.6%) with negative initial CXR results, were reviewed. Among all patients, negative initial CXR results were associated with a low probability of future adverse clinical outcomes, with negative likelihood ratios of 0.27 (95% CI, 0.23-0.31) for hospital admission, 0.24 (95% CI, 0.16-0.37) for mechanical ventilation, 0.19 (95% CI, 0.09-0.40) for ARDS, and 0.38 (95% CI, 0.29-0.51) for mortality. Among the subset of 955 patients younger than 65 years and with a duration of symptoms of at least 5 days, no patients with negative CXR results died, and the negative likelihood ratios were 0.17 (95% CI, 0.12-0.25) for hospital admission, 0.09 (95% CI, 0.02-0.36) for mechanical ventilation, and 0.09 (95% CI, 0.01-0.64) for ARDS., Interpretation: Initial CXR in adult patients suspected of having COVID-19 is a strong exclusionary test for hospital admission, mechanical ventilation, ARDS, and mortality. The value of CXR as an exclusionary test for adverse clinical outcomes is highest among young adults, patients with few comorbidities, and those with a prolonged duration of symptoms., (Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
18. Atherosclerosis inflammation and burden in young adult smokers and vapers measured by PET/MR.
- Author
-
Sahota A, Naidu S, Jacobi A, Giannarelli C, Woodward M, Fayad ZA, and Mani V
- Subjects
- Adolescent, Fluorodeoxyglucose F18, Humans, Inflammation diagnostic imaging, Positron-Emission Tomography, Smokers, Young Adult, Atherosclerosis diagnostic imaging, Electronic Nicotine Delivery Systems
- Abstract
Background and Aims: Electronic cigarette (EC) use is popular among youth, touted as a safer alternative to smoking and promoted as a tool to aid in smoking cessation. EC cardiovascular safety however is not well established. The aim of this study was to examine cardiovascular consequences of EC use by evaluating their effect on the entire atherosclerotic cascade in young adults using noninvasive combined positron emission tomography (PET)/magnetic resonance imaging (MR) and comparing EC use with age matched smokers of traditional cigarettes and nonsmoking controls., Methods: Carotid PET/MR was applied to look at vascular inflammation (18-fluorodeoxyglucose (FDG)-PET) and plaque burden (multi-contrast MR of vessel wall) from 60 18-30 year-old subjects (20 electronic cigarette users, 20 traditional smokers and 20 nonsmokers)., Results: Groups were reasonably well balanced in terms of age, gender, demographics, cardiovascular risk and most biomarkers. There were no differences in vascular inflammation as measured by 18-FDG-PET target to background ratios (TBR) between EC users, traditional cigarette smokers and nonsmokers. However, measures of carotid plaque burden - wall area, normalized wall index, and wall thickness - measured from MR were significantly higher in both traditional smokers and EC users than in nonsmokers., Conclusions: Young adult EC users, smokers and nonsmokers in our study did not exhibit vascular inflammation as defined by 18-F-FDG-PET TBR max, but smokers and EC users had significantly more carotid plaque burden compared to matched nonsmokers. Results could indicate that vaping does not cause an increase in vascular inflammation as measured by FDG-PET., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
19. USPIO-Enhanced CMR of Myocardial Inflammation: What Are We Imaging?
- Author
-
Fayad ZA and Calcagno C
- Subjects
- Humans, Inflammation diagnostic imaging, Magnetite Nanoparticles, Predictive Value of Tests, Dextrans, Heart Failure
- Abstract
Competing Interests: Funding Support and Author Disclosures Dr. Fayad is supported by grants from the National Institutes of Health, National Heart, Lung, and Blood Institute (R01HL144072, R01HL143814, R01HL135878, and P01HL131478).
- Published
- 2021
- Full Text
- View/download PDF
20. GAMER MRI: Gated-attention mechanism ranking of multi-contrast MRI in brain pathology.
- Author
-
Lu PJ, Yoo Y, Rahmanzadeh R, Galbusera R, Weigel M, Ceccaldi P, Nguyen TD, Spincemaille P, Wang Y, Daducci A, La Rosa F, Bach Cuadra M, Sandkühler R, Nael K, Doshi A, Fayad ZA, Kuhle J, Kappos L, Odry B, Cattin P, Gibson E, and Granziera C
- Subjects
- Brain diagnostic imaging, Diffusion Magnetic Resonance Imaging, Humans, Magnetic Resonance Imaging, Brain Ischemia, Stroke diagnostic imaging
- Abstract
Introduction: During the last decade, a multitude of novel quantitative and semiquantitative MRI techniques have provided new information about the pathophysiology of neurological diseases. Yet, selection of the most relevant contrasts for a given pathology remains challenging. In this work, we developed and validated a method, Gated-Attention MEchanism Ranking of multi-contrast MRI in brain pathology (GAMER MRI), to rank the relative importance of MR measures in the classification of well understood ischemic stroke lesions. Subsequently, we applied this method to the classification of multiple sclerosis (MS) lesions, where the relative importance of MR measures is less understood., Methods: GAMER MRI was developed based on the gated attention mechanism, which computes attention weights (AWs) as proxies of importance of hidden features in the classification. In the first two experiments, we used Trace-weighted (Trace), apparent diffusion coefficient (ADC), Fluid-Attenuated Inversion Recovery (FLAIR), and T1-weighted (T1w) images acquired in 904 acute/subacute ischemic stroke patients and in 6,230 healthy controls and patients with other brain pathologies to assess if GAMER MRI could produce clinically meaningful importance orders in two different classification scenarios. In the first experiment, GAMER MRI with a pretrained convolutional neural network (CNN) was used in conjunction with Trace, ADC, and FLAIR to distinguish patients with ischemic stroke from those with other pathologies and healthy controls. In the second experiment, GAMER MRI with a patch-based CNN used Trace, ADC and T1w to differentiate acute ischemic stroke lesions from healthy tissue. The last experiment explored the performance of patch-based CNN with GAMER MRI in ranking the importance of quantitative MRI measures to distinguish two groups of lesions with different pathological characteristics and unknown quantitative MR features. Specifically, GAMER MRI was applied to assess the relative importance of the myelin water fraction (MWF), quantitative susceptibility mapping (QSM), T1 relaxometry map (qT1), and neurite density index (NDI) in distinguishing 750 juxtacortical lesions from 242 periventricular lesions in 47 MS patients. Pair-wise permutation t-tests were used to evaluate the differences between the AWs obtained for each quantitative measure., Results: In the first experiment, we achieved a mean test AUC of 0.881 and the obtained AWs of FLAIR and the sum of AWs of Trace and ADC were 0.11 and 0.89, respectively, as expected based on previous knowledge. In the second experiment, we achieved a mean test F1 score of 0.895 and a mean AW of Trace = 0.49, of ADC = 0.28, and of T1w = 0.23, thereby confirming the findings of the first experiment. In the third experiment, MS lesion classification achieved test balanced accuracy = 0.777, sensitivity = 0.739, and specificity = 0.814. The mean AWs of T1map, MWF, NDI, and QSM were 0.29, 0.26, 0.24, and 0.22 (p < 0.001), respectively., Conclusions: This work demonstrates that the proposed GAMER MRI might be a useful method to assess the relative importance of MRI measures in neurological diseases with focal pathology. Moreover, the obtained AWs may in fact help to choose the best combination of MR contrasts for a specific classification problem., (Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
21. Noninvasive Imaging to Assess Atherosclerotic Plaque Composition and Disease Activity: Coronary and Carotid Applications.
- Author
-
Daghem M, Bing R, Fayad ZA, and Dweck MR
- Subjects
- Humans, Predictive Value of Tests, Rupture, Spontaneous, Carotid Arteries diagnostic imaging, Coronary Artery Disease diagnostic imaging, Coronary Vessels diagnostic imaging, Multimodal Imaging, Plaque, Atherosclerotic
- Abstract
Cardiovascular disease is one of the leading causes of mortality and morbidity worldwide. Atherosclerosis imaging has traditionally focused on detection of obstructive luminal stenoses or measurements of plaque burden. However, with advances in imaging technology it has now become possible to noninvasively interrogate plaque composition and disease activity, thereby differentiating stable from unstable patterns of disease and potentially improving risk stratification. This manuscript reviews multimodality imaging in this field, focusing on carotid and coronary atherosclerosis and how these novel techniques have the potential to complement current imaging assessments and improve clinical decision making., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
22. Trained immunity in organ transplantation.
- Author
-
Ochando J, Fayad ZA, Madsen JC, Netea MG, and Mulder WJM
- Subjects
- Animals, Graft Rejection immunology, Graft Rejection pathology, Humans, Graft Rejection prevention & control, Immune Tolerance immunology, Immunity, Innate immunology, Macrophages immunology, Organ Transplantation methods, Transplantation Immunology immunology, Transplantation Tolerance immunology
- Abstract
Consistent induction of donor-specific unresponsiveness in the absence of continuous immunosuppressive therapy and toxic effects remains a difficult task in clinical organ transplantation. Transplant immunologists have developed numerous experimental treatments that target antigen-presentation (signal 1), costimulation (signal 2), and cytokine production (signal 3) to establish transplantation tolerance. While promising results have been obtained using therapeutic approaches that predominantly target the adaptive immune response, the long-term graft survival rates remain suboptimal. This suggests the existence of unrecognized allograft rejection mechanisms that contribute to organ failure. We postulate that trained immunity stimulatory pathways are critical to the immune response that mediates graft loss. Trained immunity is a recently discovered functional program of the innate immune system, which is characterized by nonpermanent epigenetic and metabolic reprogramming of macrophages. Since trained macrophages upregulate costimulatory molecules (signal 2) and produce pro-inflammatory cytokines (signal 3), they contribute to potent graft reactive immune responses and organ transplant rejection. In this review, we summarize the detrimental effects of trained immunity in the context of organ transplantation and describe pathways that induce macrophage training associated with graft rejection., (© 2019 The Authors. American Journal of Transplantation published by Wiley Periodicals, Inc. on behalf of The American Society of Transplantation and the American Society of Transplant Surgeons.)
- Published
- 2020
- Full Text
- View/download PDF
23. Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis.
- Author
-
Senders ML, Hernot S, Carlucci G, van de Voort JC, Fay F, Calcagno C, Tang J, Alaarg A, Zhao Y, Ishino S, Palmisano A, Boeykens G, Meerwaldt AE, Sanchez-Gaytan BL, Baxter S, Zendman L, Lobatto ME, Karakatsanis NA, Robson PM, Broisat A, Raes G, Lewis JS, Tsimikas S, Reiner T, Fayad ZA, Devoogdt N, Mulder WJM, and Pérez-Medina C
- Subjects
- Animals, Atherosclerosis genetics, Atherosclerosis immunology, Atherosclerosis pathology, Disease Models, Animal, Disease Progression, Early Diagnosis, Genetic Predisposition to Disease, Lectins, C-Type immunology, Mannose Receptor, Mannose-Binding Lectins immunology, Mice, Knockout, ApoE, Multimodal Imaging, Phenotype, Rabbits, Radiopharmaceuticals pharmacokinetics, Receptors, Cell Surface immunology, Scavenger Receptors, Class E immunology, Single-Domain Antibodies metabolism, Vascular Cell Adhesion Molecule-1 immunology, Atherosclerosis diagnostic imaging, Multiparametric Magnetic Resonance Imaging, Plaque, Atherosclerotic, Positron-Emission Tomography, Radiopharmaceuticals administration & dosage, Single-Domain Antibodies administration & dosage
- Abstract
Objectives: This study sought to develop an integrative positron emission tomography (PET) with magnetic resonance imaging (MRI) procedure for accurate atherosclerotic plaque phenotyping, facilitated by clinically approved and nanobody radiotracers., Background: Noninvasive characterization of atherosclerosis remains a challenge in clinical practice. The limitations of current diagnostic methods demonstrate that, in addition to atherosclerotic plaque morphology and composition, disease activity needs to be evaluated., Methods: We screened 3 nanobody radiotracers targeted to different biomarkers of atherosclerosis progression, namely vascular cell adhesion molecule (VCAM)-1, lectin-like oxidized low-density lipoprotein receptor (LOX)-1, and macrophage mannose receptor (MMR). The nanobodies, initially radiolabeled with copper-64 (
64 Cu), were extensively evaluated in Apoe-/- mice and atherosclerotic rabbits using a combination of in vivo PET/MRI readouts and ex vivo radioactivity counting, autoradiography, and histological analyses., Results: The 3 nanobody radiotracers accumulated in atherosclerotic plaques and displayed short circulation times due to fast renal clearance. The MMR nanobody was selected for labeling with gallium-68 (68 Ga), a short-lived radioisotope with high clinical relevance, and used in an ensuing atherosclerosis progression PET/MRI study. Macrophage burden was longitudinally studied by68 Ga-MMR-PET, plaque burden by T2-weighted MRI, and neovascularization by dynamic contrast-enhanced (DCE) MRI. Additionally, inflammation and microcalcifications were evaluated by fluorine-18 (18 F)-labeled fluorodeoxyglucose (18 F-FDG) and18 F-sodium fluoride (18 F-NaF) PET, respectively. We observed an increase in all the aforementioned measures as disease progressed, and the imaging signatures correlated with histopathological features., Conclusions: We have evaluated nanobody-based radiotracers in rabbits and developed an integrative PET/MRI protocol that allows noninvasive assessment of different processes relevant to atherosclerosis progression. This approach allows the multiparametric study of atherosclerosis and can aid in early stage anti-atherosclerosis drug trials., (Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
24. New methods to image unstable atherosclerotic plaques.
- Author
-
Andrews JPM, Fayad ZA, and Dweck MR
- Subjects
- Annexin A5 chemistry, Apoptosis, Atherosclerosis diagnostic imaging, Coronary Artery Disease diagnostic imaging, Fluorodeoxyglucose F18, Gallium Radioisotopes, Humans, Hypoxia, Inflammation, Ligands, Magnetic Resonance Imaging, Myocardial Infarction diagnostic imaging, Neovascularization, Physiologic, Positron-Emission Tomography, Radiopharmaceuticals, Reproducibility of Results, Risk Assessment, Stroke diagnostic imaging, Tomography, X-Ray Computed, Diagnostic Imaging methods, Diagnostic Imaging trends, Plaque, Atherosclerotic diagnostic imaging
- Abstract
Atherosclerotic plaque rupture is the primary mechanism responsible for myocardial infarction and stroke, the top two killers worldwide. Despite being potentially fatal, the ubiquitous prevalence of atherosclerosis amongst the middle aged and elderly renders individual events relatively rare. This makes the accurate prediction of MI and stroke challenging. Advances in imaging techniques now allow detailed assessments of plaque morphology and disease activity. Both CT and MR can identify certain unstable plaque characteristics thought to be associated with an increased risk of rupture and events. PET imaging allows the activity of distinct pathological processes associated with atherosclerosis to be measured, differentiating patients with inactive and active disease states. Hybrid integration of PET with CT or MR now allows for an accurate assessment of not only plaque burden and morphology but plaque biology too. In this review, we discuss how these advanced imaging techniques hold promise in redefining our understanding of stable and unstable coronary artery disease beyond symptomatic status, and how they may refine patient risk-prediction and the rationing of expensive novel therapies., (Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
25. Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor.
- Author
-
Calcagno C, Lairez O, Hawkins J, Kerr SW, Dugas MS, Simpson T, Epskamp J, Robson PM, Eldib M, Bander I, K-Raman P, Ramachandran S, Pruzan A, Kaufman A, Mani V, Ehlgen A, Niessen HG, Broadwater J, and Fayad ZA
- Subjects
- Animals, Aortic Diseases diagnostic imaging, Aortic Diseases enzymology, Aortic Diseases pathology, Atherosclerosis diagnostic imaging, Atherosclerosis enzymology, Atherosclerosis pathology, Biomarkers blood, Contrast Media administration & dosage, Disease Models, Animal, Epoxide Hydrolases metabolism, Fluorodeoxyglucose F18 administration & dosage, Gadolinium DTPA administration & dosage, Inflammation diagnostic imaging, Inflammation enzymology, Inflammation pathology, Male, Multimodal Imaging, Predictive Value of Tests, Rabbits, Radiopharmaceuticals administration & dosage, Anti-Inflammatory Agents pharmacology, Aortic Diseases drug therapy, Atherosclerosis drug therapy, Capillary Permeability drug effects, Enzyme Inhibitors pharmacology, Epoxide Hydrolases antagonists & inhibitors, Inflammation drug therapy, Magnetic Resonance Imaging, Plaque, Atherosclerotic, Positron-Emission Tomography
- Abstract
Objectives: The authors sought to develop combined positron emission tomography (PET) dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) to quantify plaque inflammation, permeability, and burden to evaluate the efficacy of a leukotriene A4 hydrolase (LTA4H) inhibitor in a rabbit model of atherosclerosis., Background: Multimodality PET/MRI allows combining the quantification of atherosclerotic plaque inflammation, neovascularization, permeability, and burden by combined
18 F-fluorodeoxyglucose (18 F-FDG) PET, DCE-MRI, and morphological MRI. The authors describe a novel, integrated PET-DCE/MRI protocol to noninvasively quantify these parameters in aortic plaques of a rabbit model of atherosclerosis. As proof-of-concept, the authors apply this protocol to assess the efficacy of the novel LTA4H inhibitor BI691751., Methods: New Zealand White male rabbits (N = 49) were imaged with integrated PET-DCE/MRI after atherosclerosis induction and 1 and 3 months after randomization into 3 groups: 1) placebo; 2) high-dose BI691751; and 3) low-dose BI691751. All animals were euthanized at the end of the study., Results: Among the several metrics that were quantified, only maximum standardized uptake value and target-to-background ratio by18 F-FDG PET showed a modest, but significant, reduction in plaque inflammation in rabbits treated with low-dose BI691751 (p = 0.03), whereas no difference was detected in the high-fat diet and in the high-dose BI691751 groups. No differences in vessel wall area by MRI and area under the curve by DCE-MRI were detected in any of the groups. No differences in neovessel and macrophage density were found at the end of study among groups., Conclusions: The authors present a comprehensive, integrated18 F-FDG PET and DCE-MRI imaging protocol to noninvasively quantify plaque inflammation, neovasculature, permeability, and burden in a rabbit model of atherosclerosis on a simultaneous PET/MRI scanner. A modest reduction was found in plaque inflammation by18 F-FDG PET in the group treated with a low dose of the LTA4H inhibitor BI691751., (Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
26. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
- Author
-
Dweck MR, Abgral R, Trivieri MG, Robson PM, Karakatsanis N, Mani V, Palmisano A, Miller MA, Lala A, Chang HL, Sanz J, Contreras J, Narula J, Fuster V, Padilla M, Fayad ZA, and Kovacic JC
- Subjects
- Adult, Aged, Cardiomyopathies drug therapy, Cardiomyopathies pathology, Case-Control Studies, Female, Humans, Male, Middle Aged, Myocardium pathology, Positron Emission Tomography Computed Tomography, Predictive Value of Tests, Prognosis, Prospective Studies, Reproducibility of Results, Sarcoidosis drug therapy, Sarcoidosis pathology, Severity of Illness Index, Cardiomyopathies diagnostic imaging, Fluorodeoxyglucose F18 administration & dosage, Magnetic Resonance Imaging, Cine, Positron-Emission Tomography, Radiopharmaceuticals administration & dosage, Sarcoidosis diagnostic imaging
- Abstract
Objectives: The purpose of this study was to explore the diagnostic usefulness of hybrid cardiac magnetic resonance (CMR) and positron emission tomography (PET) using
18 F-fluorodeoxyglucose (FDG) for active cardiac sarcoidosis., Background: Active cardiac sarcoidosis (aCS) is underdiagnosed and has a high mortality., Methods: Patients with clinical suspicion of aCS underwent hybrid CMR/PET with late gadolinium enhancement (LGE) and FDG to assess the pattern of injury and disease activity, respectively. Patients were categorized visually as magnetic resonance (MR)+PET+ (characteristic LGE aligning exactly with increased FDG uptake), MR+PET- (characteristic LGE but no increased FDG), MR-PET- (neither characteristic LGE nor increased FDG), and MR-PET+ (increased FDG uptake in absence of characteristic LGE) and further characterized as aCS+ (MR+PET+) or aCS- (MR+PET-, MR-PET-, MR-PET+). FDG uptake was quantified using maximum target-to-normal-myocardium ratio and the net uptake rate (Ki ) from dynamic Patlak analysis. Receiver-operating characteristic methods were used to identify imaging biomarkers for aCS. FDG PET was assessed using computed tomography/PET in 19 control subjects with healthy myocardium., Results: A total of 25 patients (12 males; 54.9 ± 9.8 years of age) were recruited prospectively; 8 were MR+PET+, suggestive of aCS; 1 was MR+PET-, consistent with inactive cardiac sarcoidosis; and 8 were MR-PET-, with no imaging evidence of cardiac sarcoidosis. Eight patients were MR-PET+ (6 with global myocardial FDG uptake, 2 with focal-on-diffuse uptake); they demonstrated distinct Ki values and hyperintense maximum standardized uptake value compared with MR+PET+ patients. Similar hyperintense patterns of global (n = 9) and focal-on-diffuse (n = 2) FDG uptake were also observed in control patients, suggesting physiological myocardial uptake. Maximum target-to-normal-myocardium ratio values were higher in the aCS+ group (p < 0.001), demonstrating an area under the curve of 0.98 on receiver-operating characteristic analysis for the detection of aCS, with an optimal maximum target-to-normal myocardium ratio threshold of 1.2 (Youden index: 0.94)., Conclusions: CMR/PET imaging holds major promise for the diagnosis of aCS, providing incremental information about both the pattern of injury and disease activity in a single scan. (In Vivo Molecular Imaging [MRI] of Atherothrombotic Lesions; NCT01418313)., (Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
27. 3D black blood MR angiography of the carotid arteries. A simple sequence for plaque hemorrhage and stenosis evaluation.
- Author
-
Sigovan M, Bidet C, Bros S, Boussel L, Mechtouff L, Robson PM, Fayad ZA, Millon A, and Douek P
- Subjects
- Adult, Aged, Artifacts, Carotid Arteries pathology, Carotid Stenosis pathology, Color, Constriction, Pathologic pathology, Contrast Media, Female, Hemorrhage pathology, Humans, Image Processing, Computer-Assisted, Imaging, Three-Dimensional, Male, Middle Aged, Models, Statistical, Observer Variation, Plaque, Amyloid pathology, Plaque, Atherosclerotic pathology, Reproducibility of Results, Sensitivity and Specificity, Carotid Arteries diagnostic imaging, Constriction, Pathologic diagnostic imaging, Magnetic Resonance Angiography, Magnetic Resonance Imaging
- Abstract
Objectives: To evaluate the diagnostic performance of a new three-dimensional T1-weighted turbo-spin-echo sequence (3D T1-w TSE) compared to 3D contrast-enhanced angiography (CE-MRA) for stenosis measurement and compared to 2D T1-w TSE for intra-plaque hemorrhage (IPH) detection., Methods: Eighty three patients underwent carotid MRI, using a new elliptic-centric phase encoding T1-weighted 3D TSE sequence in addition to the clinical protocol. Two observers evaluated image quality, presence of flow artifacts, and presence of intra-plaque hemorrhage, and computed the NASCET degree of stenosis for CE-MRA and for the new sequence. Inter-observer agreement and correlation between 3D TSE and CE-MRA for NASCET stenosis was estimated using Cohen's kappa, and correlation using linear regression and Bland-Altman plots. Histology was performed on endarterectomy samples for 18 patients. Sensitivity and specificity of 2D and 3D TSE for IPH diagnosis were computed., Results: 3D TSE showed better image quality than 2D TSE (p<0.05). Interobserver agreement was good (kappa≥0.86). Correlation between 3D TSE and CE-MRA was excellent (R=0.95) for NASCET stenosis. Sensitivity and specificity for IPH diagnosis was 50% and 100% for 2D TSE and 100% and 83% for the 3D TSE., Conclusions: The new 3D T1-w TSE allows both reliable measures of carotid stenosis, with a slight overestimation compared to CE-MRA (5%), and improved IPH identification, compared to 2D TSE., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
28. MR/PET Imaging of the Cardiovascular System.
- Author
-
Robson PM, Dey D, Newby DE, Berman D, Li D, Fayad ZA, and Dweck MR
- Subjects
- Adult, Contrast Media administration & dosage, Female, Humans, Image Interpretation, Computer-Assisted, Male, Predictive Value of Tests, Prognosis, Radiopharmaceuticals administration & dosage, Severity of Illness Index, Cardiovascular Diseases diagnostic imaging, Cardiovascular System diagnostic imaging, Magnetic Resonance Imaging, Multimodal Imaging methods, Positron-Emission Tomography
- Abstract
Cardiovascular imaging has largely focused on identifying structural, functional, and metabolic changes in the heart. The ability to reliably assess disease activity would have major potential clinical advantages, including the identification of early disease, differentiating active from stable conditions, and monitoring disease progression or response to therapy. Positron emission tomography (PET) imaging now allows such assessments of disease activity to be acquired in the heart, whereas magnetic resonance (MR) scanning provides detailed anatomic imaging and tissue characterization. Hybrid MR/PET scanners therefore combine the strengths of 2 already powerful imaging modalities. Simultaneous acquisition of the 2 scans also provides added benefits, including improved scanning efficiency, motion correction, and partial volume correction. Radiation exposure is lower than with hybrid PET/computed tomography scanning, which might be particularly beneficial in younger patients who may need repeated scans. The present review discusses the expanding clinical literature investigating MR/PET imaging, highlights its advantages and limitations, and explores future potential applications., (Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
29. Coronary Artery PET/MR Imaging: Feasibility, Limitations, and Solutions.
- Author
-
Robson PM, Dweck MR, Trivieri MG, Abgral R, Karakatsanis NA, Contreras J, Gidwani U, Narula JP, Fuster V, Kovacic JC, and Fayad ZA
- Subjects
- Adult, Aged, Algorithms, Artifacts, Contrast Media administration & dosage, Feasibility Studies, Female, Fluorine Radioisotopes administration & dosage, Fluorodeoxyglucose F18 administration & dosage, Humans, Image Interpretation, Computer-Assisted, Male, Meglumine administration & dosage, Meglumine analogs & derivatives, Middle Aged, Organometallic Compounds administration & dosage, Predictive Value of Tests, Radiopharmaceuticals administration & dosage, Reproducibility of Results, Severity of Illness Index, Sodium Fluoride administration & dosage, Coronary Artery Disease diagnostic imaging, Coronary Vessels diagnostic imaging, Magnetic Resonance Imaging, Multimodal Imaging methods, Positron-Emission Tomography, Vascular Calcification diagnostic imaging
- Abstract
Objectives: The aims of this study were to describe the authors' initial experience with combined coronary artery positron emission tomographic (PET) and magnetic resonance (MR) imaging using
18 F-fluorodeoxyglucose (18 F-FDG) and18 F-sodium fluoride (18 F-NaF) radiotracers, describe common problems and their solutions, and demonstrate the feasibility of coronary PET/MR imaging in appropriate patients., Background: Recently, PET imaging has been applied to the aortic valve and regions of atherosclerosis.18 F-FDG PET imaging has become established for imaging inflammation in atherosclerosis in the aorta and carotid arteries. Moreover,18 F-NaF has emerged as a novel tracer of active microcalcification in the aortic valve and coronary arteries. Coronary PET imaging remains challenging because of the small caliber of the vessels and their complex motion. Currently, most coronary imaging uses combined PET and computed tomographic imaging, but there is increasing enthusiasm for PET/MR imaging because of its reduced radiation, potential to correct for motion, and the complementary information available from cardiac MR in a single scan., Methods: Twenty-three patients with diagnosed or documented risk factors for coronary artery disease underwent either18 F-FDG or18 F-NaF PET/MR imaging. Standard breath-held MR-based attenuation correction was compared with a novel free-breathing approach. The impact on PET image artifacts and the interpretation of vascular uptake were evaluated semiquantitatively by expert readers. Moreover, PET reconstructions with more algorithm iterations were compared visually and by target-to-background ratio., Results: Image quality was significantly improved by novel free-breathing attenuation correction. Moreover, conspicuity of coronary uptake was improved by increasing the number of algorithm iterations from 3 to 6. Elevated radiotracer uptake could be localized to individual coronary lesions using both18 F-FDG (n = 1, maximal target-to-background ratio = 1.61) and18 F-NaF (n = 7, maximal target-to-background ratio = 1.55 ± 0.37), including in 1 culprit plaque post-myocardial infarction confirmed by myocardial late gadolinium enhancement., Conclusions: The authors provide the first demonstration of successful, low-radiation (7.2 mSv) PET/MR imaging of inflammation and microcalcification activity in the coronary arteries. However, this requires specialized approaches tailored to coronary imaging for both attenuation correction and PET reconstruction., (Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)- Published
- 2017
- Full Text
- View/download PDF
30. Reply to: "β-blocker treatment of vascular disease in cocaine addiction".
- Author
-
Bachi K, Mani V, Trivieri MG, Jeyachandran D, Fayad ZA, Goldstein RZ, and Alia-Klein N
- Subjects
- Adrenergic beta-Antagonists, Humans, Cocaine, Cocaine-Related Disorders, Vascular Diseases
- Published
- 2017
- Full Text
- View/download PDF
31. Plaque microvascularization and permeability: Key players in atherogenesis and plaque rupture.
- Author
-
Calcagno C, Fayad ZA, and Raggi P
- Subjects
- Humans, Magnetic Resonance Imaging, Permeability, Vasa Vasorum, Atherosclerosis, Plaque, Atherosclerotic
- Published
- 2017
- Full Text
- View/download PDF
32. Vascular disease in cocaine addiction.
- Author
-
Bachi K, Mani V, Jeyachandran D, Fayad ZA, Goldstein RZ, and Alia-Klein N
- Subjects
- Animals, Arteries pathology, Arteries physiopathology, Cocaine-Related Disorders mortality, Cocaine-Related Disorders therapy, Humans, Prognosis, Risk Factors, Time Factors, Vascular Diseases mortality, Vascular Diseases physiopathology, Vascular Diseases prevention & control, Arteries drug effects, Central Nervous System Stimulants adverse effects, Cocaine adverse effects, Cocaine-Related Disorders complications, Vascular Diseases chemically induced, Vasoconstriction drug effects
- Abstract
Cocaine, a powerful vasoconstrictor, induces immune responses including cytokine elevations. Chronic cocaine use is associated with functional brain impairments potentially mediated by vascular pathology. Although the Crack-Cocaine epidemic has declined, its vascular consequences are increasingly becoming evident among individuals with cocaine use disorder of that period, now aging. Paradoxically, during the period when prevention efforts could make a difference, this population receives psychosocial treatment at best. We review major postmortem and in vitro studies documenting cocaine-induced vascular toxicity. PubMed and Academic Search Complete were used with relevant terms. Findings consist of the major mechanisms of cocaine-induced vasoconstriction, endothelial dysfunction, and accelerated atherosclerosis, emphasizing acute, chronic, and secondary effects of cocaine. The etiology underlying cocaine's acute and chronic vascular effects is multifactorial, spanning hypertension, impaired homeostasis and platelet function, thrombosis, thromboembolism, and alterations in blood flow. Early detection of vascular disease in cocaine addiction by multimodality imaging is discussed. Treatment may be similar to indications in patients with traditional risk-factors, with few exceptions such as enhanced supportive care and use of benzodiazepines and phentolamine for sedation, and avoiding β-blockers. Given the vascular toxicity cocaine induces, further compounded by smoking and alcohol comorbidity, and interacting with aging of the crack generation, there is a public health imperative to identify pre-symptomatic markers of vascular impairments in cocaine addiction and employ preventive treatment to reduce silent disease progression., (Copyright © 2017 Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
33. Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease.
- Author
-
Abgral R, Dweck MR, Trivieri MG, Robson PM, Karakatsanis N, Mani V, Padilla M, Miller M, Lala A, Sanz J, Narula J, Fuster V, Contreras J, Kovacic JC, and Fayad ZA
- Subjects
- Adult, Female, Heart Failure physiopathology, Humans, Male, Middle Aged, Multimodal Imaging, Myocardial Infarction physiopathology, Myocarditis physiopathology, Predictive Value of Tests, Reproducibility of Results, Sarcoidosis physiopathology, Fluorodeoxyglucose F18 administration & dosage, Heart Failure diagnostic imaging, Magnetic Resonance Imaging, Myocardial Infarction diagnostic imaging, Myocarditis diagnostic imaging, Positron-Emission Tomography, Radiopharmaceuticals administration & dosage, Sarcoidosis diagnostic imaging
- Published
- 2017
- Full Text
- View/download PDF
34. Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study.
- Author
-
Tawakol A, Ishai A, Takx RA, Figueroa AL, Ali A, Kaiser Y, Truong QA, Solomon CJ, Calcagno C, Mani V, Tang CY, Mulder WJ, Murrough JW, Hoffmann U, Nahrendorf M, Shin LM, Fayad ZA, and Pitman RK
- Subjects
- Aged, Arteries physiopathology, Atherosclerosis physiopathology, Bone Marrow metabolism, Cardiovascular Diseases diagnostic imaging, Cross-Sectional Studies, Fluorodeoxyglucose F18, Hematopoiesis physiology, Humans, Inflammation physiopathology, Longitudinal Studies, Middle Aged, Perception, Positron Emission Tomography Computed Tomography, Radiopharmaceuticals, Risk Factors, Amygdala diagnostic imaging, Amygdala metabolism, Cardiovascular Diseases metabolism, Cardiovascular Diseases psychology, Stress, Psychological metabolism
- Abstract
Background: Emotional stress is associated with increased risk of cardiovascular disease. We imaged the amygdala, a brain region involved in stress, to determine whether its resting metabolic activity predicts risk of subsequent cardiovascular events., Methods: Individuals aged 30 years or older without known cardiovascular disease or active cancer disorders, who underwent
18 F-fluorodexoyglucose PET/CT at Massachusetts General Hospital (Boston, MA, USA) between Jan 1, 2005, and Dec 31, 2008, were studied longitudinally. Amygdalar activity, bone-marrow activity, and arterial inflammation were assessed with validated methods. In a separate cross-sectional study we analysed the relation between perceived stress, amygdalar activity, arterial inflammation, and C-reactive protein. Image analyses and cardiovascular disease event adjudication were done by mutually blinded researchers. Relations between amygdalar activity and cardiovascular disease events were assessed with Cox models, log-rank tests, and mediation (path) analyses., Findings: 293 patients (median age 55 years [IQR 45·0-65·5]) were included in the longitudinal study, 22 of whom had a cardiovascular disease event during median follow-up of 3·7 years (IQR 2·7-4·8). Amygdalar activity was associated with increased bone-marrow activity (r=0·47; p<0·0001), arterial inflammation (r=0·49; p<0·0001), and risk of cardiovascular disease events (standardised hazard ratio 1·59, 95% CI 1·27-1·98; p<0·0001), a finding that remained significant after multivariate adjustments. The association between amygdalar activity and cardiovascular disease events seemed to be mediated by increased bone-marrow activity and arterial inflammation in series. In the separate cross-sectional study of patients who underwent psychometric analysis (n=13), amygdalar activity was significantly associated with arterial inflammation (r=0·70; p=0·0083). Perceived stress was associated with amygdalar activity (r=0·56; p=0·0485), arterial inflammation (r=0·59; p=0·0345), and C-reactive protein (r=0·83; p=0·0210)., Interpretation: In this first study to link regional brain activity to subsequent cardiovascular disease, amygdalar activity independently and robustly predicted cardiovascular disease events. Amygdalar activity is involved partly via a path that includes increased bone-marrow activity and arterial inflammation. These findings provide novel insights into the mechanism through which emotional stressors can lead to cardiovascular disease in human beings., Funding: None., (Copyright © 2017 Elsevier Ltd. All rights reserved.)- Published
- 2017
- Full Text
- View/download PDF
35. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.
- Author
-
Pérez-Medina C, Binderup T, Lobatto ME, Tang J, Calcagno C, Giesen L, Wessel CH, Witjes J, Ishino S, Baxter S, Zhao Y, Ramachandran S, Eldib M, Sánchez-Gaytán BL, Robson PM, Bini J, Granada JF, Fish KM, Stroes ES, Duivenvoorden R, Tsimikas S, Lewis JS, Reiner T, Fuster V, Kjær A, Fisher EA, Fayad ZA, and Mulder WJ
- Subjects
- Animals, Aorta metabolism, Aorta pathology, Aortic Diseases genetics, Aortic Diseases metabolism, Aortic Diseases pathology, Apolipoproteins E deficiency, Apolipoproteins E genetics, Atherosclerosis genetics, Atherosclerosis metabolism, Atherosclerosis pathology, Autoradiography, Disease Models, Animal, Female, Flow Cytometry, Lipoproteins, HDL pharmacokinetics, Male, Mice, Inbred C57BL, Mice, Knockout, Optical Imaging, Predictive Value of Tests, Rabbits, Radioisotopes, Radiopharmaceuticals pharmacokinetics, Reproducibility of Results, Tissue Distribution, Zirconium pharmacokinetics, Aorta diagnostic imaging, Aortic Diseases diagnostic imaging, Atherosclerosis diagnostic imaging, Lipoproteins, HDL administration & dosage, Magnetic Resonance Imaging, Molecular Imaging methods, Plaque, Atherosclerotic, Positron Emission Tomography Computed Tomography, Radiopharmaceuticals administration & dosage, Zirconium administration & dosage
- Abstract
Objectives: The goal of this study was to develop and validate a noninvasive imaging tool to visualize the in vivo behavior of high-density lipoprotein (HDL) by using positron emission tomography (PET), with an emphasis on its plaque-targeting abilities., Background: HDL is a natural nanoparticle that interacts with atherosclerotic plaque macrophages to facilitate reverse cholesterol transport. HDL-cholesterol concentration in blood is inversely associated with risk of coronary heart disease and remains one of the strongest independent predictors of incident cardiovascular events., Methods: Discoidal HDL nanoparticles were prepared by reconstitution of its components apolipoprotein A-I (apo A-I) and the phospholipid 1,2-dimyristoyl-sn-glycero-3-phosphocholine. For radiolabeling with zirconium-89 ((89)Zr), the chelator deferoxamine B was introduced by conjugation to apo A-I or as a phospholipid-chelator (1,2-distearoyl-sn-glycero-3-phosphoethanolamine-deferoxamine B). Biodistribution and plaque targeting of radiolabeled HDL were studied in established murine, rabbit, and porcine atherosclerosis models by using PET combined with computed tomography (PET/CT) imaging or PET combined with magnetic resonance imaging. Ex vivo validation was conducted by radioactivity counting, autoradiography, and near-infrared fluorescence imaging. Flow cytometric assessment of cellular specificity in different tissues was performed in the murine model., Results: We observed distinct pharmacokinetic profiles for the two (89)Zr-HDL nanoparticles. Both apo A-I- and phospholipid-labeled HDL mainly accumulated in the kidneys, liver, and spleen, with some marked quantitative differences in radioactivity uptake values. Radioactivity concentrations in rabbit atherosclerotic aortas were 3- to 4-fold higher than in control animals at 5 days' post-injection for both (89)Zr-HDL nanoparticles. In the porcine model, increased accumulation of radioactivity was observed in lesions by using in vivo PET imaging. Irrespective of the radiolabel's location, HDL nanoparticles were able to preferentially target plaque macrophages and monocytes., Conclusions: (89)Zr labeling of HDL allows study of its in vivo behavior by using noninvasive PET imaging, including visualization of its accumulation in advanced atherosclerotic lesions. The different labeling strategies provide insight on the pharmacokinetics and biodistribution of HDL's main components (i.e., phospholipids, apo A-I)., (Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
36. HDL mimetic CER-001 targets atherosclerotic plaques in patients.
- Author
-
Zheng KH, van der Valk FM, Smits LP, Sandberg M, Dasseux JL, Baron R, Barbaras R, Keyserling C, Coolen BF, Nederveen AJ, Verberne HJ, Nell TE, Vugts DJ, Duivenvoorden R, Fayad ZA, Mulder WJM, van Dongen GAMS, and Stroes ESG
- Subjects
- Aged, Contrast Media chemistry, Drug Carriers, Female, Humans, Lipoproteins chemistry, Magnetic Resonance Imaging, Male, Middle Aged, Nanomedicine, Plaque, Atherosclerotic metabolism, Positron-Emission Tomography, Tomography, X-Ray Computed, Zirconium chemistry, Apolipoprotein A-I chemistry, Phospholipids chemistry, Plaque, Atherosclerotic blood, Plaque, Atherosclerotic drug therapy, Recombinant Proteins chemistry
- Abstract
Background and Aims: Infusion of high-density lipoprotein (HDL) mimetics aimed at reducing atherosclerotic burden has led to equivocal results, which may relate in part to the inability of HDL mimetics to adequately reach atherosclerotic lesions in humans. This study evaluated delivery of recombinant human apolipoprotein A-I (apoA-I) containing HDL mimetic CER-001 in carotid plaques in patients., Methods: CER-001 was radiolabeled with the long-lived positron emitter zirconium-89 ((89)Zr) to enable positron emission tomography with computed tomography (PET/CT) imaging. Eight patients with atherosclerotic carotid artery disease (>50% stenosis) received a single infusion of unlabeled CER-001 (3 mg/kg), co-administered with 10 mg of (89)Zr-labeled CER-001 (18 MBq). Serial PET/CT imaging and contrast enhanced-magnetic resonance imaging (CE-MRI) were performed to evaluate targeted delivery of CER-001., Results: One hour after infusion, mean plasma apoA-I levels increased by 9.9 mg/dL (p = 0.026), with a concomitant relative increase in the plasma cholesterol efflux capacity of 13.8% (p < 0.001). Using serial PET/CT imaging, we showed that arterial uptake of CER-001 expressed as target-to-background ratio (TBRmax) increased significantly 24 h after infusion, and remained increased up to 48 h (TBRmax t = 10 min: 0.98; t = 24 h: 1.14 (p = 0.001); t = 48 h: 1.12 (p = 0.007)). TBRmax was higher in plaque compared with non-plaque segments (1.18 vs. 1.05; p < 0.001). Plaque TBRmax correlated with local plaque contrast enhancement (r = 0.56; p = 0.019) as assessed by CE-MRI., Conclusions: Infusion of HDL mimetic CER-001 increases plasma apoA-I concentration and plasma cholesterol efflux capacity. Our data support the concept that CER-001 targets plaque regions in patients, which correlates with plaque contrast enhancement. These clinical findings may also guide future nanomedicine development using HDL particles for drug delivery in atherosclerosis., Clinical Trial Registration: Netherlands Trial Registry - NTR5178. http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=5178., (Copyright © 2016 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
37. Non-invasive imaging of atherosclerosis regression with magnetic resonance to guide drug development.
- Author
-
Raggi P, Baldassarre D, Day S, de Groot E, and Fayad ZA
- Subjects
- Atherosclerosis pathology, Biomarkers, Clinical Trials as Topic, Disease Progression, Drug Design, Humans, Image Processing, Computer-Assisted, Plaque, Atherosclerotic pathology, Reproducibility of Results, Treatment Outcome, Atherosclerosis diagnostic imaging, Magnetic Resonance Angiography, Magnetic Resonance Imaging, Plaque, Atherosclerotic diagnostic imaging
- Abstract
Slowing of progression and inducing the regression of atherosclerosis with medical therapy have been shown to be associated with an extensive reduction in risk of cardiovascular events. This proof of concept was obtained with invasive angiographic studies but these are, for obvious reasons, impractical for sequential investigations. Non-invasive imaging has henceforth replaced the more cumbersome invasive studies and has proven extremely valuable in numerous occasions. Because of excellent reproducibility and no radiation exposure, magnetic resonance imaging (MRI) has become the non-invasive method of choice to assess the efficacy of anti-atherosclerotic drugs. The high accuracy of this technology is particularly helpful in rare diseases where the small number of affected patients makes the conduct of outcome-trials in large cohorts impractical. With MRI it is possible to assess the extent, as well as the composition, of atherosclerotic plaques and this further enhances the utility of this technology., (Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
38. LOWER, a registry of lomitapide-treated patients with homozygous familial hypercholesterolemia: Rationale and design.
- Author
-
Blom DJ, Fayad ZA, Kastelein JJ, Larrey D, Makris L, Schwamlein C, Bloeden L, and Underberg J
- Subjects
- Adult, Anticholesteremic Agents adverse effects, Anticholesteremic Agents pharmacology, Benzimidazoles adverse effects, Benzimidazoles pharmacology, Female, Humans, Hyperlipoproteinemia Type II blood, Hyperlipoproteinemia Type II epidemiology, Patient Selection, Plaque, Atherosclerotic epidemiology, Pregnancy, Safety, Time Factors, Anticholesteremic Agents therapeutic use, Benzimidazoles therapeutic use, Homozygote, Hyperlipoproteinemia Type II drug therapy, Hyperlipoproteinemia Type II genetics, Registries
- Abstract
Background: Lomitapide is an orally active selective inhibitor of microsomal triglyceride transfer protein approved as adjunctive therapy for homozygous familial hypercholesterolemia (HoFH). The Lomitapide Observational Worldwide Evaluation Registry (LOWER) is a global, long-term, prospective, observational treatment registry established as a regulatory requirement., Objectives: LOWER will evaluate the long-term safety and effectiveness of lomitapide in clinical practice. The objectives include evaluation of the occurrence of events of special interest and assessment of the long-term effectiveness of lomitapide in maintaining reduced serum lipid levels., Methods: LOWER is a noninterventional study open to eligible lomitapide-treated patients. At least 300 patients will be enrolled and followed for at least 10 years. Data will be collected in conjunction with usual care visits and analyzed annually. LOWER includes a cardiovascular imaging substudy; an independent pregnancy exposure registry is also open., Results: Events of special interest include hepatic abnormalities, gastrointestinal events, certain gastrointestinal tumors, major adverse cardiovascular events, and events associated with coagulopathy. Data will be collected on demographics, diagnosis, patient history, lomitapide dosing, concomitant treatment, lipid profile, and other laboratory results., Conclusion: LOWER will assess the long-term safety, efficacy, and patterns of use of lomitapide, increase understanding of the benefit-to-risk profile, and add to knowledge of HoFH., (Copyright © 2016 National Lipid Association. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
39. MR Imaging of Coronary Arteries and Plaques.
- Author
-
Dweck MR, Puntman V, Vesey AT, Fayad ZA, and Nagel E
- Subjects
- Coronary Artery Disease therapy, Coronary Stenosis therapy, Humans, Predictive Value of Tests, Prognosis, Severity of Illness Index, Coronary Angiography methods, Coronary Artery Disease diagnostic imaging, Coronary Stenosis diagnostic imaging, Coronary Vessels diagnostic imaging, Magnetic Resonance Angiography, Plaque, Atherosclerotic
- Abstract
Cardiac magnetic resonance offers the promise of radiation-free imaging of the coronary arteries, providing information with respect to luminal stenosis, plaque burden, high-risk plaque characteristics, and disease activity. In combination, this would provide a comprehensive, individualized assessment of coronary atherosclerosis that could be used to improve patient risk stratification and to guide treatment. However, the technical challenges involved with delivering upon this promise are considerable, requiring sophisticated approaches to both data acquisition and post-processing. In this review, we describe the current status of this technology, its capabilities, its limitations, and what will be required in the future to translate this technology into routine clinical practice., (Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
40. Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration.
- Author
-
van der Valk FM, van Wijk DF, Lobatto ME, Verberne HJ, Storm G, Willems MC, Legemate DA, Nederveen AJ, Calcagno C, Mani V, Ramachandran S, Paridaans MP, Otten MJ, Dallinga-Thie GM, Fayad ZA, Nieuwdorp M, Schulte DM, Metselaar JM, Mulder WJ, and Stroes ES
- Subjects
- Administration, Intravenous, Adult, Aged, Anti-Inflammatory Agents pharmacokinetics, Anti-Inflammatory Agents therapeutic use, Arteries drug effects, Arteries pathology, Atherosclerosis pathology, Female, Glucocorticoids pharmacokinetics, Glucocorticoids therapeutic use, Humans, Liposomes, Macrophages pathology, Male, Middle Aged, Plaque, Atherosclerotic pathology, Prednisolone pharmacokinetics, Prednisolone therapeutic use, Anti-Inflammatory Agents administration & dosage, Atherosclerosis drug therapy, Glucocorticoids administration & dosage, Macrophages drug effects, Plaque, Atherosclerotic drug therapy, Prednisolone administration & dosage
- Abstract
Drug delivery to atherosclerotic plaques via liposomal nanoparticles may improve therapeutic agents' risk-benefit ratios. Our paper details the first clinical studies of a liposomal nanoparticle encapsulating prednisolone (LN-PLP) in atherosclerosis. First, PLP's liposomal encapsulation improved its pharmacokinetic profile in humans (n=13) as attested by an increased plasma half-life of 63h (LN-PLP 1.5mg/kg). Second, intravenously infused LN-PLP appeared in 75% of the macrophages isolated from iliofemoral plaques of patients (n=14) referred for vascular surgery in a randomized, placebo-controlled trial. LN-PLP treatment did however not reduce arterial wall permeability or inflammation in patients with atherosclerotic disease (n=30), as assessed by multimodal imaging in a subsequent randomized, placebo-controlled study. In conclusion, we successfully delivered a long-circulating nanoparticle to atherosclerotic plaque macrophages in patients, whereas prednisolone accumulation in atherosclerotic lesions had no anti-inflammatory effect. Nonetheless, the present study provides guidance for development and imaging-assisted evaluation of future nanomedicine in atherosclerosis., From the Clinical Editor: In this study, the authors undertook the first clinical trial using long-circulating liposomal nanoparticle encapsulating prednisolone in patients with atherosclerosis, based on previous animal studies. Despite little evidence of anti-inflammatory effect, the results have provided a starting point for future development of nanomedicine in cardiovascular diseases., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
41. Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy.
- Author
-
Lobatto ME, Calcagno C, Otten MJ, Millon A, Ramachandran S, Paridaans MP, van der Valk FM, Storm G, Stroes ES, Fayad ZA, Mulder WJ, and Metselaar JM
- Subjects
- Animals, Anti-Inflammatory Agents pharmacokinetics, Anti-Inflammatory Agents therapeutic use, Anti-Inflammatory Agents toxicity, Aorta drug effects, Aorta pathology, Atherosclerosis pathology, Glucocorticoids pharmacokinetics, Glucocorticoids therapeutic use, Glucocorticoids toxicity, Half-Life, Humans, Liposomes, Male, Prednisolone administration & dosage, Prednisolone pharmacokinetics, Prednisolone therapeutic use, Prednisolone toxicity, Rabbits, Rats, Rats, Sprague-Dawley, Rats, Wistar, Anti-Inflammatory Agents administration & dosage, Atherosclerosis drug therapy, Chemistry, Pharmaceutical methods, Glucocorticoids administration & dosage, Prednisolone analogs & derivatives
- Abstract
The present study describes the development of a good manufacturing practice (GMP)-grade liposomal nanotherapy containing prednisolone phosphate for the treatment of inflammatory diseases. After formulation design, GMP production was commenced which yielded consistent, stable liposomes sized 100nm±10nm, with a prednisolone phosphate (PLP) incorporation efficiency of 3%-5%. Pharmacokinetics and toxicokinetics of GMP-grade liposomal nanoparticles were evaluated in healthy rats, which were compared to daily and weekly administration of free prednisolone phosphate, revealing a long circulatory half-life with minimal side effects. Subsequently, non-invasive multimodal clinical imaging after liposomal nanotherapy's intravenous administration revealed anti-inflammatory effects on the vessel wall of atherosclerotic rabbits. The present program led to institutional review board approval for two clinical trials with patients with atherosclerosis., From the Clinical Editor: In drug discovery, bringing production to industrial scale is an essential process. In this article the authors describe the development of an anti-inflammatory nanoparticle according to good manufacturing practice. As a result, this paves the way for translating laboratory studies to clinical trials in humans., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
42. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.
- Author
-
Emami H, Vucic E, Subramanian S, Abdelbaky A, Fayad ZA, Du S, Roth E, Ballantyne CM, Mohler ER, Farkouh ME, Kim J, Farmer M, Li L, Ehlgen A, Langenickel TH, Velasquez L, Hayes W, and Tawakol A
- Subjects
- Aged, Anti-Inflammatory Agents adverse effects, Aortic Diseases blood, Aortic Diseases diagnostic imaging, Aortic Diseases enzymology, Atherosclerosis blood, Atherosclerosis diagnostic imaging, Atherosclerosis enzymology, Atorvastatin therapeutic use, Biomarkers blood, C-Reactive Protein metabolism, Carotid Artery Diseases blood, Carotid Artery Diseases diagnostic imaging, Carotid Artery Diseases enzymology, Double-Blind Method, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Inflammation blood, Inflammation diagnostic imaging, Inflammation enzymology, Inflammation Mediators blood, Male, Middle Aged, Multimodal Imaging, Plaque, Atherosclerotic, Predictive Value of Tests, Protein Kinase Inhibitors adverse effects, Pyrroles adverse effects, Time Factors, Tomography, X-Ray Computed, Treatment Outcome, Triazines adverse effects, United States, p38 Mitogen-Activated Protein Kinases metabolism, Anti-Inflammatory Agents therapeutic use, Aortic Diseases drug therapy, Atherosclerosis drug therapy, Carotid Artery Diseases drug therapy, Fluorodeoxyglucose F18, Inflammation drug therapy, Positron-Emission Tomography, Protein Kinase Inhibitors therapeutic use, Pyrroles therapeutic use, Radiopharmaceuticals, Triazines therapeutic use, p38 Mitogen-Activated Protein Kinases antagonists & inhibitors
- Abstract
Objectives: This study evaluated the effect of p38 mitogen-activated protein kinase (p38MAPK) inhibitor, BMS-582949, on atherosclerotic plaque inflammation, using (18)FDG-PET imaging. p38MAPK is an important element of inflammatory pathways in atherothrombosis and its inhibition may lead to reduced inflammation within atherosclerotic plaques., Methods: Subjects with documented atherosclerosis (n = 72) on stable low-dose statin therapy and having at least one lesion with active atherosclerotic plaque inflammation in either aorta or carotid arteries were randomized to BMS-582949 (100 mg once daily), placebo, or atorvastatin (80 mg once daily), for 12 weeks. Arterial inflammation was assessed using (18)FDG-PET/CT imaging of the carotid arteries and aorta. Uptake of arterial (18)FDG was assessed as target-to-background ratio (TBR): 1) as a mean of all slices of the index vessel, and 2) within active slices of all vessels (AS: which includes only slices with significant inflammation (TBR ≥ 1.6) at the baseline)., Results: Treatment with BMS-582949 did not reduce arterial inflammation relative to placebo, (ΔTBR index: 0.10 [95% CI: -0.11, 0.30], p = 0.34; ΔTBR AS: -0.01 [-0.31, 0.28], p = 0.93) or hs-CRP (median %ΔCRP [IQR]: 33.83% [153.91] vs. 16.71% [133.45], p = 0.61). In contrast, relative to placebo, statin intensification was associated with significant reduction of hs-CRP (%ΔCRP [IQR]: -17.44% [54.68] vs. 16.71% [133.45], p = 0.04) and arterial inflammation in active slices (ΔTBRAS = -0.24 [95% CI: -0.46, -0.01], p = 0.04)., Conclusions: The findings of this study demonstrates that in stable atherosclerosis, 12 weeks of treatment with BMS-582949 did not reduce arterial inflammation or hs-CRP compared to placebo, whereas intensification of statin therapy significantly decreased arterial inflammation., (Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
43. New Applications of Cardiac Computed Tomography: Dual-Energy, Spectral, and Molecular CT Imaging.
- Author
-
Danad I, Fayad ZA, Willemink MJ, and Min JK
- Subjects
- Humans, Coronary Angiography, Coronary Stenosis diagnosis, Magnetic Resonance Angiography methods, Myocardial Perfusion Imaging methods, Tomography, X-Ray Computed methods
- Abstract
Computed tomography (CT) has evolved into a powerful diagnostic tool, and it is impossible to imagine current clinical practice without CT imaging. Because of its widespread availability, ease of clinical application, superb sensitivity for the detection of coronary artery disease, and noninvasive nature, CT has become a valuable tool within the armamentarium of cardiologists. In the past few years, numerous technological advances in CT have occurred, including dual-energy CT, spectral CT, and CT-based molecular imaging. By harnessing the advances in technology, cardiac CT has advanced beyond the mere evaluation of coronary stenosis to an imaging tool that permits accurate plaque characterization, assessment of myocardial perfusion, and even probing of molecular processes that are involved in coronary atherosclerosis. Novel innovations in CT contrast agents and pre-clinical spectral CT devices have paved the way for CT-based molecular imaging., (Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
44. A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome.
- Author
-
Gaztanaga J, Farkouh M, Rudd JH, Brotz TM, Rosenbaum D, Mani V, Kerwin TC, Taub R, Tardif JC, Tawakol A, and Fayad ZA
- Subjects
- Acute Coronary Syndrome diagnosis, Acute Coronary Syndrome enzymology, Aged, Aortitis diagnosis, Aortitis enzymology, Aortography methods, Canada, Carotid Artery Diseases diagnosis, Carotid Artery Diseases enzymology, Double-Blind Method, Female, Humans, Hydroxyurea adverse effects, Hydroxyurea therapeutic use, Lipoxygenase Inhibitors adverse effects, Male, Middle Aged, Multidetector Computed Tomography, Multimodal Imaging methods, Positron-Emission Tomography, Predictive Value of Tests, Time Factors, Treatment Outcome, United States, Vasculitis diagnosis, Vasculitis enzymology, Acute Coronary Syndrome drug therapy, Aortitis drug therapy, Carotid Artery Diseases drug therapy, Hydroxyurea analogs & derivatives, Lipoxygenase Inhibitors therapeutic use, Vasculitis drug therapy
- Abstract
Objective: Arachidonate 5-lipoxygenase (5-LO) is a key enzyme in the synthesis of leukotrienes. VIA-2291 is a potent 5-LO inhibitor, which has been shown to reduce hsCRP and noncalcified coronary plaque volume following an acute coronary syndrome (ACS). We aim to evaluate the effect of VIA-2291 on vascular inflammation compared to placebo using FDG-PET., Methods: A Phase II, randomized, double-blind, parallel-group study was conducted in 52 patients with recent ACS assigned 1:1 to either 100 mg VIA-2291 or placebo for 24 weeks. The primary outcome was the effect of VIA-2291 relative to placebo on arterial inflammation detected by (18)fluorodeoxyglucose positron emission tomography (FDG-PET) within the index vessel after 24 weeks of daily treatment, compared to baseline., Results: VIA-2291 was relatively well tolerated and was associated with a significant inhibition of the potent chemo-attractant LTB4, with a mean inhibition of activity of 92.8% (p<0.0001) at 6 weeks in the VIA-2291 group, without further significant change in inhibition at 24 weeks. However, for VIA-2291 was not associated with significant difference in inflammation (target-to-background ratio) compared to placebo at 24 weeks or 6 weeks of treatment. Further, VIA-2291 was not associated with a significant reduction in hsCRP from baseline after either 6 or 24 weeks of treatment., Conclusions: VIA-2291 is well-tolerated and effectively reduces leukotriene production. However, inhibition of 5-LO with VIA-2291 is not associated with significant reductions in vascular inflammation (by FDG-PET) or in blood inflammatory markers. Accordingly, this study does not provide evidence to support a significant anti-inflammatory effect of VIA-2291 in patients with recent ACS., (Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
45. FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: a phase II study of safety, tolerability, and anti-inflammatory activity.
- Author
-
Lehrer-Graiwer J, Singh P, Abdelbaky A, Vucic E, Korsgren M, Baruch A, Fredrickson J, van Bruggen N, Tang MT, Frendeus B, Rudd JHF, Hsieh F, Ballantyne CM, Ghoshhajra B, Rosenson RS, Koren M, Roth EM, Duprez DA, Fayad ZA, and Tawakol AA
- Subjects
- Antibodies, Monoclonal, Biomarkers blood, Double-Blind Method, Female, Fluorodeoxyglucose F18, Humans, Male, Middle Aged, Radiopharmaceuticals, Recombinant Proteins, Atherosclerosis diagnostic imaging, Atherosclerosis drug therapy, Lipoproteins, LDL antagonists & inhibitors, Positron-Emission Tomography methods
- Published
- 2015
- Full Text
- View/download PDF
46. Reply: Asymptomatic cardiovascular risk assessment: the road less traveled.
- Author
-
Friedman JI, Tang CY, Fayad ZA, Fuster V, and Narula J
- Subjects
- Humans, Cardiovascular Diseases epidemiology, Cardiovascular Diseases pathology, Cerebrovascular Disorders epidemiology, Cerebrovascular Disorders pathology, Neuroimaging
- Published
- 2015
- Full Text
- View/download PDF
47. Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humans.
- Author
-
Emami H, Singh P, MacNabb M, Vucic E, Lavender Z, Rudd JH, Fayad ZA, Lehrer-Graiwer J, Korsgren M, Figueroa AL, Fredrickson J, Rubin B, Hoffmann U, Truong QA, Min JK, Baruch A, Nasir K, Nahrendorf M, and Tawakol A
- Subjects
- Adult, Aged, Arteritis diagnostic imaging, Disease Progression, Female, Follow-Up Studies, Humans, Male, Middle Aged, Positron-Emission Tomography methods, Predictive Value of Tests, Prognosis, Prospective Studies, Radiopharmaceuticals, Risk Factors, Time Factors, Vascular Calcification diagnostic imaging, C-Reactive Protein metabolism, Fluorodeoxyglucose F18, Multimodal Imaging methods, Risk Assessment methods, Spleen metabolism
- Abstract
Objectives: This study sought to determine whether splenic activation after acute coronary syndrome (ACS) is linked to leukocyte proinflammatory remodeling and whether splenic activity independently predicts the risk of cardiovascular disease (CVD) events., Background: Pre-clinical data suggest the existence of a cardiosplenic axis, wherein activation of hematopoietic tissues (notably in the spleen) results in liberation of proinflammatory leukocytes and accelerated atherosclerotic inflammation. However, it is presently unknown whether a cardiosplenic axis exists in humans and whether splenic activation relates to CVD risk., Methods: (18)F-fluorodeoxyglucose ((18)FDG)-positron emission tomography (PET) imaging was performed in 508 individuals across 2 studies. In the first study, we performed FDG-PET imaging in 22 patients with recent ACS and 22 control subjects. FDG uptake was measured in spleen and arterial wall, whereas proinflammatory gene expression of circulating leukocytes was assessed by quantitative real-time polymerase chain reaction. In a second study, we examined the relationship between splenic tissue FDG uptake with subsequent CVD events during follow-up (median 4 years) in 464 patients who previously had undergone FDG-PET imaging., Results: Splenic activity increased after ACS and was significantly associated with multiple indices of inflammation: 1) up-regulated gene expression of proinflammatory leukocytes; 2) increased C-reactive protein; and 3) increased arterial wall inflammation (FDG uptake). Moreover, in the second study, splenic activity (greater than or equal to the median) was associated with an increased risk of CVD events (hazard ratio [HR]: 3.3; 95% confidence interval [CI]: 1.5 to 7.3; p = 0.003), which remained significant after adjustment for CVD risk factors (HR: 2.26; 95% CI: 1.01 to 5.06; p = 0.04) and for arterial FDG uptake (HR: 2.68; 95% CI: 1.5 to 7.4; p = 0.02)., Conclusions: Our findings demonstrate increased splenic metabolic activity after ACS and its association with proinflammatory remodeling of circulating leukocytes. Moreover, we observed that metabolic activity of the spleen independently predicted risk of subsequent CVD events. Collectively, these findings provide evidence of a cardiosplenic axis in humans similar to that shown in pre-clinical studies., (Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
48. Brain imaging changes associated with risk factors for cardiovascular and cerebrovascular disease in asymptomatic patients.
- Author
-
Friedman JI, Tang CY, de Haas HJ, Changchien L, Goliasch G, Dabas P, Wang V, Fayad ZA, Fuster V, and Narula J
- Subjects
- Asymptomatic Diseases, Brain metabolism, Cognition Disorders epidemiology, Diabetic Angiopathies epidemiology, Glucose metabolism, Humans, Hyperlipidemias epidemiology, Hypertension epidemiology, Hypertension pathology, Magnetic Resonance Imaging, Obesity epidemiology, Peripheral Vascular Diseases epidemiology, Risk Factors, White Matter pathology, Cardiovascular Diseases epidemiology, Cardiovascular Diseases pathology, Cerebrovascular Disorders epidemiology, Cerebrovascular Disorders pathology, Neuroimaging
- Abstract
Reviews of imaging studies assessing the brain effects of vascular risk factors typically include a substantial number of studies with subjects with a history of symptomatic cardiovascular or cerebrovascular disease and/or events, limiting our ability to disentangle the primary brain effects of vascular risk factors from those of resulting brain and cardiac damage. The objective of this study was to perform a systematic review of brain changes from imaging studies in patients with vascular risk factors but without clinically manifest cardiovascular or cerebrovascular disease or events. The 77 studies included in this review demonstrate that in persons without symptomatic cardiovascular, cerebrovascular, or peripheral vascular disease, the vascular risk factors of hypertension, diabetes mellitus, obesity, hyperlipidemia, and smoking are all independently associated with brain imaging changes before the clinical manifestation of cardiovascular or cerebrovascular disease. We conclude that the identification of brain changes associated with vascular risk factors, before the manifestation of clinically significant cerebrovascular damage, presents a window of opportunity wherein adequate treatment of these modifiable vascular risk factors may prevent the development of irreversible deleterious brain changes and potentially alter patients' clinical course., (Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
49. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study.
- Author
-
Duivenvoorden R, Mani V, Woodward M, Kallend D, Suchankova G, Fuster V, Rudd JHF, Tawakol A, Farkouh ME, and Fayad ZA
- Subjects
- Amides, Aortic Diseases blood, Aortic Diseases diagnostic imaging, Aortic Diseases drug therapy, Aortic Diseases immunology, Biomarkers blood, Carotid Artery Diseases blood, Carotid Artery Diseases diagnostic imaging, Carotid Artery Diseases drug therapy, Carotid Artery Diseases immunology, Double-Blind Method, Esters, Humans, Hypolipidemic Agents therapeutic use, Longitudinal Studies, Multimodal Imaging, Peroxidase blood, Predictive Value of Tests, Sulfhydryl Compounds therapeutic use, Time Factors, Treatment Outcome, Aorta diagnostic imaging, Aorta drug effects, Aorta immunology, Aortic Diseases diagnosis, Carotid Arteries diagnostic imaging, Carotid Arteries drug effects, Carotid Arteries immunology, Carotid Artery Diseases diagnosis, Fluorodeoxyglucose F18, Inflammation Mediators blood, Plaque, Atherosclerotic, Positron-Emission Tomography, Radiopharmaceuticals, Tomography, X-Ray Computed
- Abstract
Objectives: This study sought to longitudinally investigate the relationship between a broad spectrum of serum inflammatory biomarkers and plaque inflammation assessed by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT)., Background: Both plaque inflammation and serum biomarkers of inflammation are associated with atherothrombotic events; however, the relationship between them is unclear., Methods: We conducted a post hoc analysis of the dal-PLAQUE (A Randomized Placebo-Controlled Study of the Effect of RO4607381 on Progression or Regression of Atherosclerotic Plaque in Patients With Coronary Heart Disease [CHD] Including Patients With Other CHD Risk Factors), a randomized, placebo-controlled study of dalcetrapib, a cholesteryl ester transfer protein inhibitor, in 130 patients with coronary heart disease, or coronary heart disease risk equivalents on stable lipid-lowering therapy. Baseline and change after 3-month follow-up in inflammatory biomarker levels and baseline and change after 3-month follow-up in aorta and carotid (18)F-FDG PET/CT (mean maximum target-to-background ratio of the most diseased segment [TBRmds]) were analyzed., Results: Baseline myeloperoxidase positively correlated with baseline carotid TBRmds (rho = 0.25, p = 0.02). This correlation remained at the 3-month follow-up and was independent of traditional cardiovascular disease risk factors. Baseline lipoprotein-associated phospholipase A2 mass correlated with aorta TBRmds (rho = 0.21, p = 0.03). However, this correlation disappeared at the 3-month follow-up and was not independent of cardiovascular disease risk factors. There was no association between change from baseline in myeloperoxidase or lipoprotein-associated phospholipase A2 mass and change from baseline in aorta and carotid TBRmds. Baseline and change from baseline in high sensitivity C-reactive protein, interleukin 6, soluble P-selectin, soluble E-selectin, soluble intracellular adhesion molecule 1, soluble vascular cell adhesion molecule 1, and matrix-metalloproteinase 3 and 9 did not correlate with baseline or change from baseline in carotid or aorta TBRmds., Conclusions: Our data show that, in patients with coronary heart disease or at high risk of coronary heart disease on stable lipid-lowering therapy, circulating myeloperoxidase levels are associated with carotid plaque inflammation. (A Randomized, Placebo-controlled Study of the Effect of RO4607381 on Progression or Regression of Atherosclerotic Plaque in Patients With Coronary Heart Disease [CHD] Including Patients With Other CHD Risk Factors [dal-PLAQUE]; NCT00655473)., (Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
50. Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.
- Author
-
Millon A, Dickson SD, Klink A, Izquierdo-Garcia D, Bini J, Lancelot E, Ballet S, Robert P, Mateo de Castro J, Corot C, and Fayad ZA
- Subjects
- Animals, Aortic Diseases diagnostic imaging, Aortic Diseases drug therapy, Aortic Diseases pathology, Atherosclerosis diagnostic imaging, Atherosclerosis drug therapy, Atherosclerosis pathology, Atorvastatin, Disease Models, Animal, Disease Progression, Heptanoic Acids pharmacology, Hydroxymethylglutaryl-CoA Reductase Inhibitors pharmacology, Inflammation diagnostic imaging, Inflammation drug therapy, Inflammation pathology, Predictive Value of Tests, Pyrroles pharmacology, Rabbits, Radiography, Time Factors, Aorta, Abdominal diagnostic imaging, Aorta, Abdominal drug effects, Aorta, Abdominal pathology, Aortic Diseases diagnosis, Atherosclerosis diagnosis, Contrast Media, Dextrans, Fluorodeoxyglucose F18, Inflammation diagnosis, Magnetic Resonance Imaging, Magnetite Nanoparticles, Plaque, Atherosclerotic, Positron-Emission Tomography, Radiopharmaceuticals
- Abstract
Purpose: The aim of this study was to compare the ability of (18)F-FDG PET and iron contrast-enhanced MRI with a novel USPIO (P904) to assess change in plaque inflammation induced by atorvastatin and dietary change in a rabbit model of atherosclerosis using a combined PET/MR scanner., Materials and Methods: Atherosclerotic rabbits underwent USPIO-enhanced MRI and (18)F-FDG PET in PET/MR hybrid system at baseline and were then randomly divided into a progression group (high cholesterol diet) and a regression group (chow diet and atorvastatin). Each group was scanned again 6 months after baseline imaging. R2* (i.e. 1/T2*) values were calculated pre/post P904 injection. (18)F-FDG PET data were analyzed by averaging the mean Standard Uptake Value (SUVmean) over the abdominal aorta. The in vivo imaging was then correlated with matched histological sections stained for macrophages., Results: (18)F-FDG PET showed strong FDG uptake in the abdominal aorta and P904 injection revealed an increase in R2* values in the aortic wall at baseline. At 6 months, SUVmean values measured in the regression group showed a significant decrease from baseline (p = 0.015). In comparison, progression group values remained constant (p = 0.681). R2* values showed a similar decreasing trend in the regression group suggesting less USPIO uptake in the aortic wall. Correlations between SUVmean or Change in R2* value and macrophages density (RAM-11 staining) were good (R(2) = 0.778 and 0.707 respectively)., Conclusion: This experimental study confirms the possibility to combine two functional imaging modalities to assess changes in the inflammation of atherosclerotic plaques. (18)F-FDG-PET seems to be more sensitive than USPIO P904 to detect early changes in plaque inflammation., (Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.